Canary Speech

Canary Speech is a technology company that uses AI-driven vocal digital biomarkers for conversational speech virtual health monitoring. The company's vocal biomarker technology enables voice to be used as a vital sign, ushering in a new era of machine learning in healthcare. Using only 20 seconds of conversational speech, its patented vocalbiomarker technology models acoustic and linguistic features and returns analysis.

Artificial Intelligence (AI) Health Care Information Technology Machine Learning Software

$13M

Latest Funding

Series A

Latest Funding Stage

2024-06-12

Funding Date

29

Employees

United States

Location

Provo, Utah

City & State

Sales-Ready Summary

Canary Speech recently raised $13M in Series A funding and utilizes HubSpot for marketing automation, making them a potential target for sales and marketing tools to optimize their outreach and lead generation efforts.

Key Contacts
Unlock Contact Information

Upgrade to access founder details

Upgrade Now
Open Positions
View Careers Page
Hiring For
n/a
Unlock Tech Stack Data

Upgrade to access technology insights

Upgrade Now

Similar Startups

Archipelo
Archipelo  Logo

The Archipelo Developer Security Posture Management Platform provides organizations with—the underlying system of record to capture SDLC event data tied to developer actions. Archipelo empowers security, GRC, and engineering teams to proactively identify, triage, and mitigate risks before they impact your business.

Workhelix
Workhelix Logo

Workhelix brings together advanced research and comprehensive data to assess organizations' generative AI opportunities and which tasks can be accelerated with available technology, enabling businesses to navigate the opportunity landscape with data and reports, rather than relying on gut and instinct.

Subscript
Subscript  Logo

Subscript is a platform that allows users to develop, understand, and manage subscription businesses. This enables members to update the database, calculate measures such as ARR, net revenue retention, CAC, LTV, ARPA, and so on, and analyze customer segments.

Eikon Therapeutics
Eikon Therapeutics  Logo

Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.